AIP
AMGN icon

Arrowpoint Investment Partners’s Amgen AMGN Stock Holding History

Arrowpoint Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,400
Closed -$1.52M – 107
2025
Q3 		$1.52M Buy
+5,400
New +$1.57M 1.52% 20
2025
Q1 		– Sell
-9,100
Closed -$2.37M – 920
2024
Q4 		$2.37M Buy
+9,100
New +$2.7M 0.49% 33

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Arrowpoint Investment Partners's AMGN Position: Q2 2026 in Review

Arrowpoint Investment Partners sold out of Amgen (AMGN) in Q2 2026, closing a stake of 4,934 shares — an estimated $1.74M sold.

Arrowpoint Investment Partners first reported a position in AMGN in Q4 2024 and held it in 4 quarters. The position peaked at $1.95M in Q4 2025. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Arrowpoint Investment Partners reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 4,934 Amgen shares in Q2 2026, an estimated $1.74M.
  • Arrowpoint Investment Partners first reported a position in Amgen in Q4 2024 and held it in 4 quarters.
  • Arrowpoint Investment Partners's Amgen position peaked at $1.95M in Q4 2025.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.